In a rare disease having a small population size, direct sequencing data has given some single nucleotide mutations present in diseased individuals (Samples = 500 , controls = 500)for example). But the novel point mutation which are found is say only in 1/500. Can this mutation be called as novel and snp?
Secondly if this mutation is also present in healthy individuals, then it should be considered or not?
Some point mutations found in affected individuals (say 4/500), but also in controls (3/500), then can it be called as a mutation?
Thanks for your kind help
I have bunch of variants in one gene but the information regarding their presence in same patient or not is not provided in the research papers, I went through.
Ah, so this isn't your own data. You'll have to contact the authors and ask them.